Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy

OBJECTIVE: Patients with rheumatoid arthritis (RA) are at increased risk of herpes zoster (HZ), and the risk appears to be increased in patients treated with tofacitinib. The aim of this study was to evaluate whether concomitant treatment with conventional synthetic disease‐modifying antirheumatic d...

詳細記述

保存先:
書誌詳細
出版年:Arthritis Rheumatol
主要な著者: Winthrop, Kevin L., Curtis, Jeffrey R., Lindsey, Stephen, Tanaka, Yoshiya, Yamaoka, Kunihiro, Valdez, Hernan, Hirose, Tomohiro, Nduaka, Chudy I., Wang, Lisy, Mendelsohn, Alan M., Fan, Haiyun, Chen, Connie, Bananis, Eustratios
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2017
主題:
Rheumatoid Arthritis
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5656820/
https://ncbi.nlm.nih.gov/pubmed/28845604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40189
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料